Trial Profile
A Phase 1 Trial of Lapatinib in Combination With 1) Sirolimus or 2) Metformin in Advanced Cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Lapatinib (Primary) ; Metformin (Primary) ; Sirolimus (Primary)
- Indications Cancer
- Focus Adverse reactions
- 23 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 25 Apr 2013 Status changed from active, no longer recruiting to recruiting as reported by M.D. Anderson Cancer Center record.
- 24 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by M.D. Anderson Cancer Center record.